Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 8889711 Pyrazolopyridine derivatives as anticancer agent
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 23 Oct, 2024
"update inverses"
Golden AI
edited on 23 Oct, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12122767 Bicyclic heterocycles as FGFR inhibitors
0
Edits on 11 Sep, 2024
"update inverses"
Golden AI
edited on 11 Sep, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12083124 Bicyclic heterocycles as FGFR inhibitors
0
Edits on 21 Aug, 2024
"update inverses"
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12065494 Combination therapy comprising an FGFR inhibitor and a Nectin-4 targeting agent
0
Edits on 3 Jul, 2024
"update inverses"
Golden AI
edited on 3 Jul, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12024517 Salts of an FGFR inhibitor
0
Edits on 19 Jun, 2024
"update inverses"
Golden AI
edited on 19 Jun, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12012409 Bicyclic heterocycles as FGFR inhibitors
0
Edits on 29 Mar, 2024
"update inverses"
Golden AI
edited on 29 Mar, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11939331 Tricyclic heterocycles as FGFR inhibitors
0
Edits on 13 Dec, 2023
"update inverses"
Golden AI
edited on 13 Dec, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11840534 Substituted tricyclic compounds as FGFR inhibitors
0
Edits on 27 Sep, 2023
"Add patent inventor(s)"
Golden AI
edited on 27 Sep, 2023
Edits made to:
Infobox
(
+8
properties)
Infobox
Patent Inventor Names
Arnaud Marchand
0
El Bachir Kaloun
0
Hugues Bienayme
0
Karim Bedjeguelal
0
Nicolas Rahier
0
Patrice Mayer
0
Philippe Schambel
0
Rémi Rabot
0
Edits on 16 Jul, 2023
"Remove leading 0 from patent number"
Golden AI
edited on 16 Jul, 2023
Edits made to:
Infobox
(
+1
/
-1
properties)
US Patent 08889711 Pyrazolopyridine derivatives as anticancer agent
US Patent 8889711 Pyrazolopyridine derivatives as anticancer agent
Infobox
Patent Number
08889711
0
Patent Number
8889711
0
Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=08889711
0
Edits on 5 Apr, 2023
"Entity importer update"
Golden AI
edited on 5 Apr, 2023
Infobox
Is a
Patent
0
Patent Jurisdiction
United States Patent and Trademark Office
0
Patent Number
08889711
0
Date of Patent
November 18, 2014
0
Patent Application Number
13500757
0
Date Filed
October 13, 2010
0
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=08889711
0
Patent Primary Examiner
Niloofar Rahmani
0
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox
(
+1
properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=08889711
Edits on 27 Dec, 2021
"Created via: Entity Importer"
Golden AI
created this topic on 27 Dec, 2021
Edits made to:
Infobox
(
+7
properties)
US Patent 08889711 Pyrazolopyridine derivatives as anticancer agent
Infobox
Is a
Patent
Patent jurisdiction
United States Patent and Trademark Office
Patent number
08889711
Date of patent
November 18, 2014
Patent application number
13500757
Date Filed
October 13, 2010
Patent primary examiner
Niloofar Rahmani
Find more entities like US Patent 8889711 Pyrazolopyridine derivatives as anticancer agent
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE